LU70985A1 - - Google Patents

Info

Publication number
LU70985A1
LU70985A1 LU70985A LU70985A LU70985A1 LU 70985 A1 LU70985 A1 LU 70985A1 LU 70985 A LU70985 A LU 70985A LU 70985 A LU70985 A LU 70985A LU 70985 A1 LU70985 A1 LU 70985A1
Authority
LU
Luxembourg
Application number
LU70985A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU70985A1 publication Critical patent/LU70985A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
LU70985A 1973-09-26 1974-09-24 LU70985A1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19732349024 DE2349024A1 (de) 1973-09-26 1973-09-26 6beta,7beta-epoxy-1alpha,2alphamethylen-d-homo-4-pregnen-3,20-dione

Publications (1)

Publication Number Publication Date
LU70985A1 true LU70985A1 (cg-RX-API-DMAC7.html) 1975-03-06

Family

ID=5894080

Family Applications (1)

Application Number Title Priority Date Filing Date
LU70985A LU70985A1 (cg-RX-API-DMAC7.html) 1973-09-26 1974-09-24

Country Status (16)

Country Link
US (1) US3965128A (cg-RX-API-DMAC7.html)
JP (1) JPS5059362A (cg-RX-API-DMAC7.html)
AR (1) AR202946A1 (cg-RX-API-DMAC7.html)
AU (1) AU7374074A (cg-RX-API-DMAC7.html)
BE (1) BE820381A (cg-RX-API-DMAC7.html)
DD (1) DD114599A5 (cg-RX-API-DMAC7.html)
DE (1) DE2349024A1 (cg-RX-API-DMAC7.html)
DK (1) DK507974A (cg-RX-API-DMAC7.html)
FI (1) FI280574A7 (cg-RX-API-DMAC7.html)
FR (1) FR2244492A1 (cg-RX-API-DMAC7.html)
IL (1) IL45629A0 (cg-RX-API-DMAC7.html)
LU (1) LU70985A1 (cg-RX-API-DMAC7.html)
NL (1) NL7412747A (cg-RX-API-DMAC7.html)
NO (1) NO743449L (cg-RX-API-DMAC7.html)
SE (1) SE7412058L (cg-RX-API-DMAC7.html)
ZA (1) ZA746131B (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999025703A1 (en) * 1997-11-14 1999-05-27 Merck & Co., Inc. Immunosuppressant tetracyclic triterpenes
US6022890A (en) * 1997-11-14 2000-02-08 Merck & Co., Inc. Immunosuppressant tetracyclic triterpenes
US7846915B2 (en) * 2004-10-20 2010-12-07 Resverlogix Corporation Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases
WO2007016525A2 (en) * 2005-07-29 2007-02-08 Resverlogix Corp. Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
PT2118074E (pt) 2007-02-01 2014-03-20 Resverlogix Corp Compostos para a prevenção e tratamento de doenças cardiovasculares
US8114995B2 (en) 2008-06-26 2012-02-14 Resverlogix Corp. Methods of preparing quinazolinone derivatives
ES2542835T3 (es) 2009-01-08 2015-08-12 Resverlogix Corporation Compuestos para la prevención y el tratamiento de enfermedades cardiovasculares
NZ617779A (en) 2009-03-18 2015-08-28 Resverlogix Corp Novel anti-inflammatory agents
US9757368B2 (en) 2009-04-22 2017-09-12 Resverlogix Corp. Anti-inflammatory agents
PT2773354T (pt) 2011-11-01 2019-07-17 Resverlogix Corp Formulações orais de libertação imediata para quinazolinonas substituídas
US9765039B2 (en) 2012-11-21 2017-09-19 Zenith Epigenetics Ltd. Biaryl derivatives as bromodomain inhibitors
US9073878B2 (en) 2012-11-21 2015-07-07 Zenith Epigenetics Corp. Cyclic amines as bromodomain inhibitors
JP2016507496A (ja) 2012-12-21 2016-03-10 ゼニス・エピジェネティクス・コーポレイションZenith Epigenetics Corp. ブロモドメイン阻害剤としての新規複素環式化合物
CN114984016A (zh) 2015-03-13 2022-09-02 雷斯韦洛吉克斯公司 用于治疗补体相关疾病之组合物及治疗方法

Also Published As

Publication number Publication date
NO743449L (cg-RX-API-DMAC7.html) 1975-04-28
SE7412058L (cg-RX-API-DMAC7.html) 1975-03-27
BE820381A (fr) 1975-03-26
DD114599A5 (cg-RX-API-DMAC7.html) 1975-08-12
ZA746131B (en) 1975-09-24
FI280574A7 (cg-RX-API-DMAC7.html) 1975-03-27
FR2244492A1 (cg-RX-API-DMAC7.html) 1975-04-18
AR202946A1 (es) 1975-07-31
DK507974A (cg-RX-API-DMAC7.html) 1975-06-09
US3965128A (en) 1976-06-22
JPS5059362A (cg-RX-API-DMAC7.html) 1975-05-22
DE2349024A1 (de) 1975-04-10
NL7412747A (nl) 1975-04-01
AU7374074A (en) 1976-04-01
IL45629A0 (en) 1974-11-29

Similar Documents

Publication Publication Date Title
AR201758A1 (cg-RX-API-DMAC7.html)
AU465372B2 (cg-RX-API-DMAC7.html)
AR201235Q (cg-RX-API-DMAC7.html)
AR201231Q (cg-RX-API-DMAC7.html)
AU474593B2 (cg-RX-API-DMAC7.html)
AU474838B2 (cg-RX-API-DMAC7.html)
AU465453B2 (cg-RX-API-DMAC7.html)
AU471343B2 (cg-RX-API-DMAC7.html)
AU465434B2 (cg-RX-API-DMAC7.html)
DK507974A (cg-RX-API-DMAC7.html)
AR201229Q (cg-RX-API-DMAC7.html)
AU472848B2 (cg-RX-API-DMAC7.html)
AU466283B2 (cg-RX-API-DMAC7.html)
AU477823B2 (cg-RX-API-DMAC7.html)
AR195948A1 (cg-RX-API-DMAC7.html)
AR200885A1 (cg-RX-API-DMAC7.html)
AR201432A1 (cg-RX-API-DMAC7.html)
AU471461B2 (cg-RX-API-DMAC7.html)
AR196382A1 (cg-RX-API-DMAC7.html)
AR210729A1 (cg-RX-API-DMAC7.html)
AU447540B2 (cg-RX-API-DMAC7.html)
AU1891376A (cg-RX-API-DMAC7.html)
AU5288973A (cg-RX-API-DMAC7.html)
AR196123Q (cg-RX-API-DMAC7.html)
AR196212Q (cg-RX-API-DMAC7.html)